JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇺🇾📋

Import Authorization

MSP import authorization for cannabis into Uruguay

Import / Export Verified 2026-04-20

Workflow steps

  1. Medical Import Intent
    Import for medical research or pharmaceutical use only. Uruguay is a domestic-focused market — no commercial export program like Colombia or Portugal. MSP (Ministerio de Salud Pública) authorization required for all cannabis imports.
    • MSP import authorization
    • Medical/pharmaceutical end-use only
    • Importing entity must hold MSP license
    • No commercial export program exists
  2. MSP Authorization Application
    Apply to Ministerio de Salud Pública for import authorization. Uruguay's import regime is restrictive — focused on medical and research use. No general commercial import pathway for adult-use product.
    • MSP license for importing entity
    • Product specifications and COA
    • End-use declaration (medical/research)
    • Exporting country export permit
    • GMP certificate from country of origin
  3. MSP authorization granted?
    MSP evaluates import application. Uruguay's domestic market orientation means import approvals are limited to specific medical or research needs.
  4. Address MSP Queries
    Respond to MSP requests for additional documentation. Common issues: insufficient end-use justification, GMP certificate gaps, or product specification concerns.
    • Additional medical/research justification
    • Updated product documentation
    • Revised end-use declaration
  5. Uruguayan Customs
    Customs clearance at Montevideo port or Carrasco International Airport. MSP authorization must be presented. Narcotic import declaration under Single Convention 1961.
    • MSP import authorization (original)
    • Exporting country export permit
    • COA per batch
    • Customs narcotic declaration
  6. Import Cleared ✓
    Product released for authorized medical or research use in Uruguay. Domestic-focused market — import volumes remain modest.
Three Access ChannelsGMP Pathway